Fundraising Fox
Promaxo
Oakland, US · Delaware corporation · 6 known investors
Find your way into Promaxo
Sign up to see every warm intro you have to Promaxo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Promaxo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Promaxo develops a compact, office-based MRI system designed for point-of-care use, with applications including image-guided prostate interventions. The company operates in the medical imaging and medical device sector.
Founders & leadership
AV
Amit VohraFounder, President & CEOAmit Vohra is an executive officer and director at Promaxo, a medical device company developing a compact, office-based MRI system for point-of-care imaging applications including image-guided interventions. He brings extensive experience in medical device and biotechnology company leadership, product commercialization, and regulatory compliance including FDA and ISO 13485 standards.
MB
Michael BartholomewEVP & Co-Founder, Inside Director BoDMichael Bartholomew is an executive officer and director at Promaxo, which develops compact, office-based MRI systems for point-of-care imaging. He has experience in medical device and biopharmaceutical product development and commercialization across domestic and international markets.
DK
Dinesh KumarChief Operations Officer2018–2025Dinesh Kumar is an executive with over two decades of experience commercializing medical technologies in urology, surgical robotics, imaging, and regulated medical devices. He is currently Executive Officer at Promaxo and previously founded Blend Health, which develops wearable technology for continuous blood pressure and cardiovascular health monitoring.
Board
Investors · 6
Almond Tree Capitallisted by Almond Tree CapitalDavis
How we know: Almond Tree Capital's portfolio page · Not right? Tell us
Angel Physicians Fundlisted by Angel Physicians Fund
How we know: Angel Physicians Fund's portfolio page · Not right? Tell us
Frontier Path VClisted by Frontier Path VCLondon
How we know: Frontier Path VC's portfolio page · Not right? Tell us
Zynext VenturesreportedPennington
How we know: funding news · press coverage · Not right? Tell us
Also in the syndicate · 1
Huami Corporationlead
Reported raises · per SEC filings
Form D private placements$60.9M disclosed across 4 of 5 rounds · 2017–2024
▶$41.9MraisedJul 2024 · 163 investors · BiotechnologyRule 506(b)
▶$41.9MraisedJul 2024 · 163 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amit VohraExecutive Officer, Director
- Michael BartholomewExecutive Officer, Director
- Jonathan ChenDirector
- Derek HenneckeDirector
- Dushyant ChipalkattyDirector
- Dinesh KumarExecutive Officer
- Offering amount
- $57.3M
- Amount sold
- $41.9M
- Minimum investment
- $1
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.2MraisedJan 2021 · 4 investors · BiotechnologyRule 506(b)
▶$4.2MraisedJan 2021 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael BartholomewExecutive Officer, Director
- Jonathan ChenDirector
- Amit VohraExecutive Officer, Director
- Dan McCormickDirector
- Offering amount
- $5M
- Amount sold
- $4.2M
- Minimum investment
- $1
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$11MraisedMay 2020 · 69 investors · BiotechnologyRule 506(b)
▶$11MraisedMay 2020 · 69 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Amit VohraExecutive Officer, Director
- Dan McCormickDirector
- Dushyant ChipalkattyDirector
- Michael BartholomewExecutive Officer, Director
- Jonathan ChenDirector
- Offering amount
- $30.6M
- Amount sold
- $11M
- Minimum investment
- $1
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$3.8MraisedSep 2017 · 10 investors · BiotechnologyRule 506(b)
▶$3.8MraisedSep 2017 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael BartholomewExecutive Officer, Director
- Amit VohraExecutive Officer, Director
- Dushyant ChipalkattyDirector
- Offering amount
- $7.6M
- Amount sold
- $3.8M
- Minimum investment
- $1
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Promaxo went on to found or lead other companies.
Related companies · 6
MDxHealthMDxHealth is a commercial-stage precision diagnostics company offering molecular diagnostic tests to guide the diagnosis and treatment of prostate cancer and other urologic diseases. Its tests use proprietary genetic, epigenetic, and molecular technologies and serve physicians, patients, payers, and providers.
MIRA DX, Inc.MiraDx develops genetic biomarker tests, such as PREVIOTOX and PROSTOX Ultra, that help physicians assess cancer patients' risk of treatment-related toxicity and response to therapies like immunotherapy and radiation. The company applies novel biomarkers, including the inherited KRAS-variant, to support more personalized cancer care decisions.
CancerresearchukCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
Profound MedicalProfound Medical develops real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue. The company's TULSA-PRO therapeutic system enables precise ablation of diseased prostate tissue in a commercial-stage medical technology setting.
American Cancer Society (ACS)The American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities. It serves individuals seeking cancer information and those who want to support cancer research and patient advocacy efforts.
UclahealthUCLA Health is a major academic health system providing patient care across five hospitals and 290 clinics in Southern California and the Central Coast, alongside research and medical education. The organization conducts pioneering research in oncology, transplantation, neurosurgery, and other specialties, having contributed to the development of numerous FDA-approved treatments.
Companies working in the same space as Promaxo.
In the news
Frequently asked questions
- What does Promaxo do?
- Promaxo develops a compact, office-based MRI system designed for point-of-care use, with applications including image-guided prostate interventions. The company operates in the medical imaging and medical device sector.
- Who founded Promaxo?
- Promaxo was founded by Amit Vohra.
- Who are Promaxo's investors?
- Promaxo's investors include Almond Tree Capital, Angel Physicians Fund, Band of Angels, Frontier Path VC, Zynext Ventures.
- How much funding has Promaxo raised?
- Promaxo has disclosed $60.9M raised across 4 of its 5 known rounds.
- Where is Promaxo headquartered?
- Promaxo is headquartered in Oakland, US.